These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 7516514

  • 1. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
    Miller RC, Wolf EJ, Gould M, Macri CJ, Charnas LR.
    Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
    Wenstrom KD, Owen J, Davis RO, Brumfield CG.
    Obstet Gynecol; 1996 Feb; 87(2):213-6. PubMed ID: 8559526
    [Abstract] [Full Text] [Related]

  • 3. Amniotic fluid alpha fetoprotein (AFAFP) and maternal serum alpha fetoprotein (MSAFP) in abdominal pregnancies: correlation with extent and site of placental implantation and clinical implications.
    Shumway JB, Greenspoon JS, Khouzami AN, Platt LD, Blakemore KJ.
    J Matern Fetal Med; 1996 Feb; 5(3):120-3. PubMed ID: 8796780
    [Abstract] [Full Text] [Related]

  • 4. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
    Henriques CU, Damm P, Tabor A, Pedersen JF, Mølsted-Pedersen L.
    Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
    [Abstract] [Full Text] [Related]

  • 5. Combined ultrasonography and amniocentesis for pregnant women with elevated serum alpha-fetoprotein. Revising the risk estimate.
    Schell DL, Drugan A, Brindley BA, Zador IE, Johnson MP, Schwartz DB, Evans MI.
    J Reprod Med; 1990 May; 35(5):543-6. PubMed ID: 1693689
    [Abstract] [Full Text] [Related]

  • 6. Risk of fetal chromosomal anomalies in patients with elevated maternal serum alpha-fetoprotein.
    Warner AA, Pettenati MJ, Burton BK.
    Obstet Gynecol; 1990 Jan; 75(1):64-6. PubMed ID: 1688649
    [Abstract] [Full Text] [Related]

  • 7. [Increased AFP in maternal serum as an indication for invasive diagnosis].
    Gremm B, Sohn C, Beldermann F, Bastert G.
    Zentralbl Gynakol; 1997 Jan; 119(11):560-6. PubMed ID: 9480612
    [Abstract] [Full Text] [Related]

  • 8. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
    Cusick W, Rodis JF, Vintzileos AM, Albini SM, McMahon M, Campbell WA.
    J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
    [Abstract] [Full Text] [Related]

  • 9. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
    Silver RM, Draper ML, Byrne JL, Ashwood EA, Lyon JL, Branch DW.
    Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
    [Abstract] [Full Text] [Related]

  • 10. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
    Zarzour SJ, Gabert HA, Diket AL, St Amant M, Miller JM.
    J Matern Fetal Med; 1998 Jan; 7(6):304-7. PubMed ID: 9848697
    [Abstract] [Full Text] [Related]

  • 11. Congenital nephrosis as a cause of elevated alpha-fetoprotein.
    Albright SG, Warner AA, Seeds JW, Burton BK.
    Obstet Gynecol; 1990 Nov; 76(5 Pt 2):969-71. PubMed ID: 1699188
    [Abstract] [Full Text] [Related]

  • 12. Elevated maternal serum alpha-fetoprotein and amniotic fluid alpha-fetoprotein after multifetal pregnancy reduction.
    Grau P, Robinson L, Tabsh K, Crandall BF.
    Obstet Gynecol; 1990 Dec; 76(6):1042-5. PubMed ID: 1700349
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diagnostic use of meternal serum alpha-fetoprotein levels.
    Cowchock FS, Jackson LG.
    Obstet Gynecol; 1976 Jan; 47(1):63-8. PubMed ID: 54892
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss.
    Maher JE, Davis RO, Goldenberg RL, Boots LR, DuBard MB.
    Obstet Gynecol; 1994 Jan; 83(1):138-41. PubMed ID: 7505911
    [Abstract] [Full Text] [Related]

  • 17. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
    Widlund KF, Gottvall T.
    Acta Obstet Gynecol Scand; 2007 Jan; 86(2):167-71. PubMed ID: 17364279
    [Abstract] [Full Text] [Related]

  • 18. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
    Anfuso S, Soncini E, Bonelli P, Piantelli G, Gramellini D.
    Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
    [Abstract] [Full Text] [Related]

  • 19. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY, Luthy DA, Zebelman AM, Williams MA, Lieppman RE, Hickok DE.
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA, Peterson CJ, French CA, Saller DN, Arvan DA.
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.